Citation

Farkas RH, Unger EF, Temple R. New Engl. J. Med. 2013; 369(8): 689-691.

Affiliation

From the Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.

Copyright

(Copyright © 2013, Massachusetts Medical Society)

DOI

10.1056/NEJMp1307972

PMID

23923991

Abstract

Zolpidem (Ambien, Sanofi) is the most widely used prescription drug for insomnia and one of the most commonly used drugs in the United States. Treatment of insomnia, which has important effects on patients' quality of life, may also have larger public health benefits. In its 2006 report, the Institute of Medicine (IOM) Committee on Sleep Medicine and Research concluded that sleep deprivation and sleep disorders represent an unaddressed public health problem that has substantial health consequences and leads to high health care costs.(1) The IOM noted that one of every five serious injuries from driving accidents can be attributed to . . .

Language: en